Streptomyces spectabilis Spectinomycin

Streptomyces spectabilis Spectinomycin Streptomyces spheroldes Novobiocin... 

Spectinomycin Spectinomycin, 4a,7,9-trihydroxy-2-methyl-6,8-fcw-(methylamino)-per-hydroxypyrano-[2,3-b]benzodioxan-4-one (32.7.1), which is isolated from products of the actinomycete Streptomyces spectabilis, is an aminocyclitol, yet it is not an aminoglycoside antibiotic since it does not contain either an amino sugar region or a glycoside bond [316-324]. 

Spectinomycin is an aminocyclitol antibiotic produced by Streptomyces spectabilis. It is indicated for use via the oral and intramuscular or subcutaneous routes in the treatment of a variety of enteric, respiratory, and other infections of cattle, sheep, swine and poultry. Recommended dosages are 7.5-12.5 mg/kg bw for intramuscular injections and 1-5 mg/bird for subcutaneous injections in poultry. Spectinomycin is frequently combined with lincomycin and administered either intramuscularly at 15 mg/kg bw to calves, sheep, and swine (15), and at... 

The spectinomycins (O Fig. 20) have a fused three-ring system which consists of a 4,5-disub-stituted actinamine and an ulose. Spectinomycin is produced by Streptomyces spectabilis and Streptomyces flavopersius. It has been clinically used for treatment of the gonorrhea infection. A related structure has been discovered with spenolimycin which was isolated from the culture filtrate of Streptomyces gilvospiralis. Efforts have been directed toward semisynthetic aminoglycoside antibiotics to treat multi-drug resistant bacteria [94]. 

---